Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using the molecular classification of glioblastoma to inform personalized treatment.

The Journal of pathology - 1 Jan 2014

Olar Adriana, Aldape Kenneth D

Abstract excerpt

Glioblastoma is the most common and most aggressive diffuse glioma, associated with short survival and uniformly fatal outcome, irrespective of treatment. It is characterized by morphological, genetic and gene-expression heterogeneity. The current standard of treatment is maximal surgical resection, followed by radiation, with concurrent and adjuvant chemotherapy. Due to the heterogeneity, most tumours develop...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Brain Neoplasms
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Glioblastoma

Share to Molecular Targeted Therapy

Share to Patient Selection

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 24114756
DOI: 10.1002/path.4282
PMCID: PMC4138801

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using the molecular classification of glioblastoma to inform personalized treatment.PMID 24114756Read ↗

Molecular Pathogenesis and Emerging Treatment for Glioblastoma.Semantic proximity Read ↗

Molecular biology of glioblastoma: Classification and mutational locations.Semantic proximity Read ↗

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Glioblastoma Biology, Genetics and Possible TherapiesSemantic proximity Read ↗

Current clinical management of patients with glioblastoma.Semantic proximity Read ↗

Molecular, histopathological, and genomic variants of glioblastoma.Semantic proximity Read ↗

Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.Semantic proximity Read ↗

Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.Semantic proximity Read ↗

Glioblastoma genetics: in rapid flux.Semantic proximity Read ↗

Glioblastoma: An Update in Pathology, Molecular Mechanisms and BiomarkersSemantic proximity Read ↗

Principles in the Management of GlioblastomaSemantic proximity Read ↗

Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.